Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/32888
Title: The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective
Authors: Alroughani, Raed
VAN WIJMEERSCH, Bart 
Al Khaboori, Jabber
Alsharoqi, Isa Ahmed
Ahmed, Samar F.
Hassan, Ali
Inshasi, Jihad
Krieger, Derk W.
Shakra, Mustafa
Shatila, Ahmed Osman
Szolics, Miklos
Khallaf, Mohamed
Ezzat, Aly
Issue Date: 2020
Publisher: SAGE PUBLICATIONS LTD
Source: Therapeutic Advances in Neurological Disorders, 13 (Art N° 1756286420954119)
Abstract: Over the past decade, the development of high-efficacy disease-modifying therapies (DMTs) has been responsible for more effective management of relapsing-remitting multiple sclerosis (RRMS). However, the gaps in optimal care for this complex disease remain. Alemtuzumab (Lemtrada (R)) is a highly efficacious DMT that shows better patient outcomes and therapeutic benefits, but its use is under-recognized in the Gulf region. Experts in the care of multiple sclerosis shared their opinions based on study data and daily clinical experience in identifying the appropriate patient profile suitable for alemtuzumab's therapeutic benefits. Age, disease activity and severity, disability status, physician experience, and economic condition are some of the key indicators for alemtuzumab use.
Notes: Alroughani, R (corresponding author), Al Amiri Hosp, Dept Med, Div Neurol, Kuwait, Kuwait.
alroughani@gmail.com
Other: Alroughani, R (corresponding author), Al Amiri Hosp, Dept Med, Div Neurol, Kuwait, Kuwait. alroughani@gmail.com
Keywords: alemtuzumab;disease modifying therapies;Gulf region;multiple sclerosis;patient profiles;relapsing-remitting
Document URI: http://hdl.handle.net/1942/32888
ISSN: 1756-2856
e-ISSN: 1756-2864
DOI: 10.1177/1756286420954119
ISI #: WOS:000570713200001
Category: A1
Type: Journal Contribution
Validations: ecoom 2021
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
1756286420954119.pdfPublished version194.02 kBAdobe PDFView/Open
Show full item record

WEB OF SCIENCETM
Citations

3
checked on Mar 23, 2024

Page view(s)

20
checked on Sep 6, 2022

Download(s)

10
checked on Sep 6, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.